MedTrace Logo

Impact of RUTF on Body Composition, Anemia and Zinc Status of PLWHA

NCT02433743 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 65

Last updated 2015-05-05

No results posted yet for this study

Summary

A clinical trial was conducted in 65 PLWH randomly allocated to receive standard hospital diet alone (Control group: n=33), or the diet combined with 100 g/day of RUTF (RUTF group: n=32). Individual dietary intakes were measured and compared to the Recommended Dietary Allowances (RDA) for PLWH. Body composition was measured by bio-impedance analysis (BIA), hemoglobin by HemoCue and plasma zinc concentration by atomic absorption spectrometry and adjusted to infection (CRP and α1-AGP). All measures were conducted at baseline, 3 weeks and after 9 weeks home-based follow up.

Conditions

  • HIV-infection/Aids
  • Malnutrition

Interventions

DIETARY_SUPPLEMENT

Ready-to-use therapeutic food (RUTF)

HIV-infected patients were randomly allocated to receive standard hospital diet (Control: n=33), or this diet combined with 100 g/day of RUTF (RUTF: n=32). All patients was follow-up during hospitalisation and 9 week after discharge at home

Sponsors & Collaborators

  • UNICEF

    collaborator OTHER

  • Cheikh Anta Diop University, Senegal

    lead OTHER

Principal Investigators

  • Salimata Wade, Professor · Université Cheikh Anta Diop de Dakar

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
78 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2012-06-30
Completion
2012-07-31

Countries

  • Senegal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02433743 on ClinicalTrials.gov